Rare Ventures

Rare Ventures is a venture studio dedicated to the creation and development of biotechnology companies focused on rare diseases. The firm utilizes a venture creation model to identify high-potential academic research and transform it into clinical-stage therapeutic programs. By providing centralized management and specialized expertise in orphan drug development, Rare Ventures aims to accelerate the delivery of life-changing treatments to patients with underserved genetic conditions. The organization was founded by Chris Adams, a veteran of the rare disease accelerator Cydan, and operates as a platform to de-risk early-stage science for future investment and commercialization.